Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Regulatory Toxicology and Pharmacology : RTP
|
November 18, 2019
Qualification of impurities based on metabolite data
Lars Weidolf, Thomas Andersson, Joel P Bercu, et al.
Angewandte Chemie (International Ed. in English)
|
January 1, 2024
Engineering Biocatalysts for the C-H Activation of Fatty Acids by Ancestral Sequence Reconstruction
Bethan S Jones, Connie M Ross, Gabriel Foley, et al.
Protein Science : a Publication of the Protein Society
|
June 16, 2026
Substrate scope of ancestral versus modern family-1 glycosidases
Luis I Gutierrez-Rus, Dušan Petrović, Pascal Schneider, et al.
Chembiochem : a European Journal of Chemical Biology
|
June 12, 2023
Interrogation of an Enzyme Library Reveals the Catalytic Plasticity of Naturally Evolved [4+2] Cyclases
Katja Zorn, Catherine R Back, Rob Barringer, et al.
Chemical Science
|
August 29, 2025
Chemoenzymatic total synthesis of the antibiotic (-)-13-deoxytetrodecamycin using the Diels-Alderase TedJ
S Joe Russell, Catherine R Back, Christopher Perry, et al.
Journal of the American Chemical Society
|
October 2, 2023
Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters
Arnau Rué Casamajo, Yuqi Yu, Christian Schnepel, et al.
Journal of Medicinal Chemistry
|
April 2, 2019
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery Disease
Malin Lemurell, Johan Ulander, Hans Emtenäs, et al.
Journal of Medicinal Chemistry
|
January 8, 2016
Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties
Anders Johansson, Christian Löfberg, Madeleine Antonsson, et al.
Chemical Science
|
August 15, 2024
Antibiotic origami: selective formation of spirotetronates in abyssomicin biosynthesis
Sbusisiwe Z Mbatha, Catherine R Back, Andrew J Devine, et al.
Journal of Medicinal Chemistry
|
March 15, 2019
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease
Daniel Pettersen, Johan Broddefalk, Hans Emtenäs, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Regulatory Toxicology and Pharmacology : RTP
|
November 18, 2019
Qualification of impurities based on metabolite data
Lars Weidolf, Thomas Andersson, Joel P Bercu, et al.
Angewandte Chemie (International Ed. in English)
|
January 1, 2024
Engineering Biocatalysts for the C-H Activation of Fatty Acids by Ancestral Sequence Reconstruction
Bethan S Jones, Connie M Ross, Gabriel Foley, et al.
Protein Science : a Publication of the Protein Society
|
June 16, 2026
Substrate scope of ancestral versus modern family-1 glycosidases
Luis I Gutierrez-Rus, Dušan Petrović, Pascal Schneider, et al.
Chembiochem : a European Journal of Chemical Biology
|
June 12, 2023
Interrogation of an Enzyme Library Reveals the Catalytic Plasticity of Naturally Evolved [4+2] Cyclases
Katja Zorn, Catherine R Back, Rob Barringer, et al.
Chemical Science
|
August 29, 2025
Chemoenzymatic total synthesis of the antibiotic (-)-13-deoxytetrodecamycin using the Diels-Alderase TedJ
S Joe Russell, Catherine R Back, Christopher Perry, et al.
Journal of the American Chemical Society
|
October 2, 2023
Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters
Arnau Rué Casamajo, Yuqi Yu, Christian Schnepel, et al.
Journal of Medicinal Chemistry
|
April 2, 2019
Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery Disease
Malin Lemurell, Johan Ulander, Hans Emtenäs, et al.
Journal of Medicinal Chemistry
|
January 8, 2016
Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties
Anders Johansson, Christian Löfberg, Madeleine Antonsson, et al.
Chemical Science
|
August 15, 2024
Antibiotic origami: selective formation of spirotetronates in abyssomicin biosynthesis
Sbusisiwe Z Mbatha, Catherine R Back, Andrew J Devine, et al.
Journal of Medicinal Chemistry
|
March 15, 2019
Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease
Daniel Pettersen, Johan Broddefalk, Hans Emtenäs, et al.
Page
of 6